Drug-resistant tuberculosis

被引：6

作者：

Böttger, EC ^{[1
]}

机构：

[1] Univ Zurich, Inst Med Microbiol, CH-8028 Zurich, Switzerland

来源：

LANCET | 2001年 / 357卷 / 9264期

关键词：

D O I：

10.1016/S0140-6736(00)04427-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1288 / 1289

页数：2

共 5 条

[1] MUTATION POSITION AND TYPE OF SUBSTITUTION IN THE BETA-SUBUNIT OF THE RNA-POLYMERASE INFLUENCE IN-VITRO ACTIVITY OF RIFAMYCINS IN RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS [J].

BODMER, T ;

ZURCHER, G ;

IMBODEN, P ;

TELENTI, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) :345-348

[2] Standard short-course chemotherapy for drug-resistant tuberculosis -: Treatment outcomes in 6 countries [J].

Espinal, MA ;

Kim, SJ ;

Suarez, PG ;

Kam, KM ;

Khomenko, AG ;

Migliori, GB ;

Baéz, J ;

Kochi, A ;

Dye, C ;

Raviglione, MC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (19) :2537-2545

[3]

Inderlied Clark B., 1995, P1385

[4] Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis [J].

Meier, A ;

Sander, P ;

Schaper, KJ ;

Scholz, M ;

Bottger, EC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2452-2454

[5] Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis [J].

Yang, B ;

Koga, H ;

Ohno, H ;

Ogawa, K ;

Fukuda, M ;

Hirakata, Y ;

Maesaki, S ;

Tomono, K ;

Tashiro, T ;

Kohno, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) :621-628

← 1 →